PHILADELPHIA, Oct. 27, 2024 (GLOBE NEWSWIRE) — Securities fraud lawsuits have been filed against Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI). The lawsuits have been filed

SHANGHAI, Oct. 27, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, in partnership with AMD, the high performance and adaptive computing

Singapore, Oct. 25, 2024 (GLOBE NEWSWIRE) — SIMPPLE LTD. (Nasdaq: SPPL) (the “Company” or “SIMPPLE”), an advanced technology solution provider in the emerging property-technology (“PropTech”) space, today announced that on

Long-term improvements observed in the quartet of findings defining disease modification supports atacicept’s potential to prevent kidney failure in patients with IgAN; Long-term results from the ORIGIN Phase 2b study

New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months1 Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate (eGFR) slope – a key measure of kidney function

The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after the last dose of felzartamab Felzartamab, an investigational anti-CD38 monoclonal

PHILADELPHIA, Oct. 26, 2024 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed against WEBTOON Entertainment Inc. (“WEBTOON” or the “Company”) (NASDAQ: WBTN). The lawsuit has been filed

New York, NY, Oct. 25, 2024 (GLOBE NEWSWIRE) — Andretti Acquisition Corp. II (Nasdaq: POLEU) (the “Company”) announced today that, commencing October 28, 2024, holders of the units sold in

Washington, DC, Oct. 26, 2024 (GLOBE NEWSWIRE) — IMMEDIATE RELEASE MEDIA ALERT Hey NCAA & Mountain West!!! Women’s Sports are for Women Only ICONS Highlights Rally to Support University of

Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS Study, PROTECT open-label extension, and real-world evidence presentations highlight initial

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Selected for late-breaking oral presentation at ASN kidney week, the world’s premier

COSTA MESA, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) — El Pollo Loco, the nation’s leading fire-grilled chicken restaurant, is turning up the heat with a limited-time test of its all-new

SAN FRANCISCO, Oct. 25, 2024 (GLOBE NEWSWIRE) — In a release issued on October 24, 2024 under the same headline by SIFT, please note that in the sub headline and first

STATESBORO, Ga., Oct. 25, 2024 (GLOBE NEWSWIRE) — Cemil Emre Yavas and his research team have achieved a remarkable 97.97% accuracy in earthquake prediction for Los Angeles, a high-risk seismic

New York, New York, Oct. 25, 2024 (GLOBE NEWSWIRE) — Onyx Acquisition Co. I. (the “Company”) (Nasdaq: ONYX), a special purpose acquisition company, today announced that it will redeem all